StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Wednesday. The brokerage issued a hold rating on the stock.

Milestone Scientific Price Performance

Shares of MLSS opened at $0.56 on Wednesday. The company’s fifty day moving average is $0.65 and its two-hundred day moving average is $0.70. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35.

Milestone Scientific (NYSE:MLSS) last announced its quarterly earnings data on Friday, March 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $2.26 million during the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%.

Institutional Investors Weigh In On Milestone Scientific

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC bought a new position in shares of Milestone Scientific Inc. (NYSE:MLSS) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 27,936 shares of the company’s stock, valued at approximately $26,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.